Evaluate Ltd

Evaluate Ltd is a leading provider of trusted commercial intelligence and predictive analytics, serving the pharmaceutical industry with unparalleled insights. Evaluate Ltd empowers its clients to refine and transform their understanding of the global biopharma market's past, present, and future, enabling them to make well-informed decisions and drive success. With a focus on delivering actionable intelligence, Evaluate Ltd offers solutions that provide the time and confidence needed to turn understanding into insight and insight into strategic action.

Located at its primary address at 3 More London Riverside, London, SE1 2RE, GB, and with additional offices at 60 State St, Boston, Massachusetts 02109, US, and Akasaka Garden City 4F, 4-15-1 Akasaka, Tokyo, Tokyo 107-0052, JP, Evaluate Ltd delivers a comprehensive suite of services. These include Evaluate Pharma, offering a trusted global view of pharmaceutical market performance with consensus forecasts, company financials, and pipeline analysis. Evaluate Omnium provides a dynamic view of development risk and commercial return, offering game-changing insight into pharma asset potential. Additionally, Evaluate Ltd offers specialized forecasting solutions and CDMO Intelligence, as well as consulting and analytics services to address unique scientific, clinical, and commercial challenges.

Through a combination of leading data sources, deep pharmaceutical expertise, robust methodologies, and advanced analytics, Evaluate Ltd ensures that teams make the right decisions to drive growth. Evaluate Ltd is committed to providing the highest quality data and industry insights, backed by gold standard financial forecast methodologies. We invite the manager of Evaluate Ltd to create a customized and exclusive company showcase and product listing on our platform to further enhance your company's visibility and commercial development.